Neutrophil elastase-mediated increase in airway temperature during inflammation  Annika Schmidt, Azzaq Belaaouaj, Rosi Bissinger, Garrit Koller, Laurette.

Slides:



Advertisements
Similar presentations
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Advertisements

Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
Alveolar inflammation in cystic fibrosis
Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice  Ximena.
Anmin Tan, André Ziegler, Bernhard Steinbauer, Joachim Seelig 
Christopher C. Miller, Christopher A
BIIL 284 reduces neutrophil numbers but increases P
Neil E. Alexis, Marianne S. Muhlebach, David B. Peden, Terry L. Noah 
Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa  Magnus Paulsson,
Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment  Winnie Ridderberg, Karen E.M.
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients  Helle Krogh Johansen, Samuel.
Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice  Bob Lubamba, François Huaux, Jean Lebacq, Etienne Marbaix,
IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection  Hannah K. Bayes, Neil D. Ritchie, Christopher Ward,
A small molecule neutrophil elastase inhibitor, KRP-109, inhibits cystic fibrosis mucin degradation  Shashi Chillappagari, Christian Müller, Poornima.
Lactate in cystic fibrosis sputum
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 
Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis  P. Gonçalves.
Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis  Jiangchao Zhao, Charles R. Evans, Lisa A. Carmody,
Pseudomonas aeruginosa in cystic fibrosis: Pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease  Malin Carlsson, Swati.
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
D. Worlitzsch, C. Rintelen, K. Böhm, B. Wollschläger, N. Merkel, M
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Regional ventilation in cystic fibrosis measured by electrical impedance tomography  Zhanqi Zhao, Rainald Fischer, Inéz Frerichs, Ullrich Müller-Lisse,
Raphaël Chiron, Y. Yaël Grumbach, Nga V. T
Pro-inflammatory effect of cystic fibrosis sputum microparticles in the murine lung  Chiara Porro, Sante Di Gioia, Teresa Trotta, Silvia Lepore, Maria.
Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia  P.Ø. Jensen, C. Moser, A. Kharazmi,
Amanda L. Brennan, Khin M. Gyi, David M
Lucas R. Hoffman, Hemantha D. Kulasekara, Julia Emerson, Laura S
Protease–antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions  Julia Hentschel, Nele Fischer, Wibke K. Janhsen,
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function  William R. Hunt, Beth R. Helfman,
Evaluation of salt supplementation in CF infants
Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients  J.L. Fothergill,
Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn 
Vitamin A and lung function in CF
Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies  Niels Høiby  Journal of Cystic.
Treatment response of airway clearance assessed by single-breath washout in children with cystic fibrosis  Chiara Abbas, Florian Singer, Sophie Yammine,
A.H. Gifford  Journal of Cystic Fibrosis 
M. Wouthuyzen-Bakker, F.A.J.A. Bodewes, H.J. Verkade 
Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis  Elizabeth F. Shead, Charles S. Haworth,
Predicting hypoxia in cystic fibrosis patients during exposure to high altitudes  Wolfgang Kamin, Birthe Fleck, Dirk-Mathias Rose, Oliver Thews, Wolfgang.
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Christiane I. -U. Chen, Susanne Schaller-Bals, Karl P
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Early pulmonary disease manifestations in cystic fibrosis mice
Heiko Heerklotz, Joachim Seelig  Biophysical Journal 
Calculation of the capnographic index based on expiratory molar mass–volume-curves — A suitable tool to screen for cystic fibrosis lung disease  Susanne.
Cytokine gene polymorphisms and severity of CF lung disease
Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance  P. Goncalves-Vidigal,
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease  Patrizia Risé, Sonia Volpi, Claudio Colombo, Rita Francesca.
Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis  K.L. Moffitt, S.L. Martin, A.M. Jones, A.K. Webb,
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions  Gerard McCaughey,
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Alina A. Ionescu, Lisette S. Nixon, Dennis J. Shale 
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
Comparison of two tobramycin nebuliser solutions: Pharmacokinetic, efficacy and safety profiles of T100 and TNS  Dorota Sands, Ewa Sapiejka, Grzegorz.
Stability of interleukin 8 and neutrophil elastase in bronchoalveolar lavage fluid following long-term storage  Luke J. Berry, Barbara Sheil, Luke Garratt,
Soluble inflammation markers in nasal lavage from CF patients and healthy controls  Natalie Beiersdorf, Matthias Schien, Julia Hentschel, Wolfgang Pfister,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
James H. Hull, Rachel Garrod, Timothy B. Ho, Ronald K. Knight, John R
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Absence of a gender gap in survival
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Presentation transcript:

Neutrophil elastase-mediated increase in airway temperature during inflammation  Annika Schmidt, Azzaq Belaaouaj, Rosi Bissinger, Garrit Koller, Laurette Malleret, Ciro D'Orazio, Martino Facchinelli, Bernhard Schulte- Hubbert, Antonio Molinaro, Otto Holst, Jutta Hammermann, Monika Schniederjans, Keith C. Meyer, Soeren Damkiaer, Giorgio Piacentini, Baroukh Assael, Kenneth Bruce, Susanne Häußler, John J. LiPuma, Joachim Seelig, Dieter Worlitzsch, Gerd Döring  Journal of Cystic Fibrosis  Volume 13, Issue 6, Pages 623-631 (December 2014) DOI: 10.1016/j.jcf.2014.03.004 Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Neutrophil elastase (NE)/α1-proteinase inhibitor (α1-PI) complex formation increases local temperature during infection/inflammation. A, B, exhaled breath temperature correlates with lung function in CF patients. Exhaled breath temperature was determined in 56 CF patients (red) and 20 healthy individuals (black) using the end-expiratory manoeuver plateau temperature (PLET) method. Forced expiratory volume in 1s was determined by spirometry. The Student's t-test was used for statistical evaluation. C, local temperature in neutrophil-dominated mucus plugs is increased above airway luminal temperature and normal body temperature in CF patients. For in vivo temperature measurements in airways of 5 CF patients and 3 individuals with bronchial carcinoma, a computerized Clark type oxygen probe was inserted in the working channel of the bronchoscope and guided under video control into the right upper lobe where measurements were made in mucopurulent material and in the airway lumen. D, E, NE/α1-PI complex formation is exothermic. The enthalpy of the complex formation between NE and α1-PI was determined by isothermal titration calorimetry (ITC). The calorimeter cell (Vcell=0.203ml) contained NE at a concentration of 15μM. The syringe contained α1-PI at a concentration of 150μM. Measurement performed at 35°C in 150mM NaCl, 10mM sodium phosphate, pH7.4. (D) Heat flow. Each exothermic peak corresponds to the injection of 2μL α1-PI solution into the calorimeter cell. (E) Binding enthalpy as a function of the molar ratio α1-PI/NE. ■: experimental data; solid line: theoretical prediction based on a 1:1 binding model of NE with α1-PI using a binding constant of K=5×107M−1 and a binding enthalpy of ΔH0=−18.5kcal/mol. F, Pouch airspace temperature in wild type mice is increased compared with that in neutrophil elastase-deficient (NE−/−) mice. In groups of 5 NE−/− mice air pouches were generated which were challenged with 107CFU/pouch of the P. aeruginosa strain H103. After 4days, the temperature in the pouch airspace was determined (for details see text). G, H, Total cell counts do not differ in pouches of wild type and NE−/− mice. Pouches were lavaged with PBS, and total and differential counts were performed immediately by routing methods using cytospins and morphologic analyses. Polymorphnuclear cells (PMN): WT vs NE−/−: p=0.40; Mononuclear cells (MNC): WT vs NE−/−: p=0.43. Journal of Cystic Fibrosis 2014 13, 623-631DOI: (10.1016/j.jcf.2014.03.004) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 P. aeruginosa grown anaerobically at an elevated temperature. A, The P. aeruginosa strain PAO1 was grown in liquid media at 30°C, 37°C, 38°C and 39°C under anaerobic conditions for 96h and bacterial CFU were determined using routine methods. B, At 39°C the P. aeruginosa strain PAO1 and the alginate overexpressing mutant PAO1 SD4 (∆ mucA) were significantly compromised compared to the nonmucoid strain PAO1 SD40 (∆ mucA/algT) under anaerobic conditions after 96h incubation. Journal of Cystic Fibrosis 2014 13, 623-631DOI: (10.1016/j.jcf.2014.03.004) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 P. aeruginosa does not produce a polysaccharide O-antigen chain when grown at 38°C under anaerobic conditions. The LPS fractions of P. aeruginosa PAO1 and an environmental P. aeruginosa isolate, grown at 30°C and 38°C aerobically or anaerobically, were extracted from whole cell lysate and subjected to SDS gel electrophoresis. LPS analysis reveals lack of the O-side chain at 38°C under anaerobic growth. Journal of Cystic Fibrosis 2014 13, 623-631DOI: (10.1016/j.jcf.2014.03.004) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions